FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/106822 [Registered on: 24/03/2026] Trial Registered Prospectively
Last Modified On: 24/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Comparative Clinical Study on the Efficacy of Udumbaradi Taila and Guduchidantyadi Malhar in the Management of Acharana Yonivyapad (Pruritus Vulvae) 
Scientific Title of Study   Comparative clinical study to evaluate the efficacy of Udumbaradi Taila with Guduchidantyadi Malhar in the management of Acharana Yonivyapad with special reference to Pruritus Vulvae. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Akanksha Shukla 
Designation  PG Scholar 
Affiliation  Chandra Shekhar Singh Ayurvedic Sansthan 
Address  Department of Prasuti Tantra

Kaushambi
UTTAR PRADESH
212213
India 
Phone  639344955  
Fax    
Email  dr.akanksha955@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Akanksha Shukla 
Designation  PG SCHOLAR 
Affiliation  Chandra Shekhar Singh Ayurvedic Sansthan 
Address  Department of Prasuti Tantra

Kaushambi
UTTAR PRADESH
212213
India 
Phone  639344955  
Fax    
Email  dr.akanksha955@gmail.com  
 
Details of Contact Person
Public Query
 
Name  PROF DR MAYANK KESHARWANEE 
Designation  PROFESSOR 
Affiliation  Chandra Shekhar Singh Ayurvedic Sansthan 
Address  Department of Prasuti Tantra

Kaushambi
UTTAR PRADESH
212213
India 
Phone  7376383840  
Fax    
Email  mayankkesharwani9@gmail.com  
 
Source of Monetary or Material Support  
CHANDRA SHEKHAR SINGH AYURVED Chikitsalaya evam Shod Kendra, KOILAHA, KAUSHAMBI (U.P.)212213 INDIA 
 
Primary Sponsor  
Name  Chandra Shekhar Singh Ayurved Chikitsalaya evam Shodh Kedra 
Address  Koilaha, Kaushambi (U.P.) 212213 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Akanksha Shukla  Chandra Shekhar Singh Ayurvedic Chikitsalaya evam shodh kendra  OPD No 105, Prasuti Tantra evam Stri Rog
Kaushambi
UTTAR PRADESH 
6393440955

dr.akanksha955@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committe CSSAS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N908||Other specified noninflammatory disorders of vulva and perineum. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Udumbaradi Taila, Reference: Bhaishajya Ratnavali, Route: Topical, Dosage Form: Taila, Dose: 5(ml), Frequency: bd, Bhaishajya Kal: Antarabhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: Applied locally over vulval region after proper cleaning twice daily for 30 days.
2Comparator ArmDrugClassical(1) Medicine Name: Guduchidantyadi Malhar, Reference: Bhaishajya Ratnavali, Route: Topical, Dosage Form: Taila, Dose: 5(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: Applied locally over vulval region after proper cleaning twice daily for 30 days for comparative evaluation.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Adult female who are in age group of 18-45 years.
Only married patient.
Patients having pruritus vulvae as a cardinal symptom with or without vaginal discharge 
 
ExclusionCriteria 
Details  Patients below 18yrs and above 45yrs.
Patient unwilling to participate in trial.
Patients after menopause.
Patient of uterine prolapse &Carcinoma.
Patient on oral contraceptives, or using intrauterine contraceptive devices.
Patients with diabetes mellitus, tuberculosis, jaundice, severe HTN.
Patients with extensive chronic cervicitis, fibroid and malignancy.
VDRL, HIV, HBsAg ,HCV positive patient. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Relief in Yoni Kandu (itching)  3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Yoni srava
Daurgandhya
Vedana
Dyspareunia
Vaginal pH 
90 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   06/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [dr.akanksha955@gmail.com].

  6. For how long will this data be available start date provided 20-03-2026 and end date provided 19-05-2026?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NA
Brief Summary  

Acharana Yonivyapad is a gynecological disorder described in Ayurveda, mainly caused due to improper genital hygiene, leading to symptoms like itching (kandu) in the vulval region. It is clinically correlated with Pruritus Vulvae, which is commonly associated with vaginal discharge, burning sensation, dyspareunia and discomfort. Conventional treatments such as antibiotics and antifungals may cause side effects and disturb normal vaginal flora.

The present study is a randomized comparative clinical trial to evaluate the efficacy of Udumbaradi Taila Yoni Pichu and Guduchidantyadi Malhar in the management of Acharana Yonivyapad. A total of 60 patients will be randomly divided into two groups. Group A will receive Udumbaradi Taila Yoni Pichu and Group B will receive Guduchidantyadi Malhar for local application, for 7 days after cessation of menstruation for 3 consecutive cycles.

The outcome will be assessed based on improvement in symptoms like itching, vaginal discharge, malodour, pain, dyspareunia and vaginal pH. This study aims to evaluate a safe, effective and cost-efficient Ayurvedic management for Pruritus Vulvae.

 
Close